RYVU THERAPEUTICS S.A.

Insiders Ryvu Therapeutics S.A.

Equities

RVU

PLSELVT00013

Delayed Warsaw S.E. Other stock markets 05:28:08 2024-05-02 am EDT			5-day change	1st Jan Change
49 ^PLN	-1.01%		-3.54%	-14.78%

Mar. 13	Ryvu Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 06	Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ryvu Therapeutics Announces Executive Changes	22-07-26	CI
Ryvu Therapeutics S.A. Appoints Hendrik Nogai to the Role of Chief Medical Officer	22-03-15	CI
Ryvu Therapeutics S.A. Appoints Hendrik Nogai as Chief Medical Officer, Effective February 1, 2022	22-01-17	CI
Ryvu Therapeutics Appoints Vatnak Vat-Ho as Chief Business Officer	21-04-26	CI
Ryvu Therapeutics Announces Board and Executive Changes	19-09-19	CI
Selvita S.A. Appoints Setareh Shamsili, M.D., Ph.D., as Chief Medical Officer	19-07-25	CI
Selvita S.A. Plans to Separate into Two Companies; Announces Management Changes	19-03-28	CI
Selvita SA Appoints Steffen Heeger as Chief Medical Officer	18-02-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer